Issue 18, 2023

Polymorph II of hydroxyurea 150 years after its first synthesis

Abstract

A new polymorph of hydroxyurea (HU) was crystallized 150 years after its first synthesis. Due to its medicinal use in neoplastic diseases and sickle cell anemia, a high throughput screen of HU binary cocrystals was attempted. Instead of a cocrystal, an isoenergetic form II crystallized concomitantly with urea in methanol.

Graphical abstract: Polymorph II of hydroxyurea 150 years after its first synthesis

Supplementary files

Article information

Article type
Communication
Submitted
16 Feb 2023
Accepted
11 Apr 2023
First published
11 Apr 2023

CrystEngComm, 2023,25, 2712-2716

Polymorph II of hydroxyurea 150 years after its first synthesis

S. K. Rai, S. Tothadi, M. Arhangelskis, C. P. George, R. G. Gonnade and A. K. Nangia, CrystEngComm, 2023, 25, 2712 DOI: 10.1039/D3CE00163F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements